The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. Year to date metric has recorded a loss of -45.13%.However, over the last six months, we can see a stronger performance of -59.40%. Over the last 30 days, the price of CVAC has leaped by -21.43%. And in the last five days, it has fallen by -5.33%.
CureVac N.V. experienced a rather shaky stock market performance. The highest value in the past year was recorded at $12.36 on 06/23/23 and the lowest value was $2.34 on 04/25/24.
52-week price history of CVAC Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. CureVac N.V.’s current trading price is -81.31% away from its 52-week high, while its distance from the 52-week low is -1.28%. The stock’s price range during this period has varied between$2.34 and $12.36. The CureVac N.V.’s shares, which operate in the Healthcare, saw a trading volume of around 1.24 million for the day, a figure considerably higher than their average daily volume of 0.79 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
CureVac N.V. (CVAC) has experienced a quarterly decline of -37.06% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 517.16M and boasts a workforce of 1100 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 3.66, with a change in price of -3.09. Similarly, CureVac N.V. recorded 1,079,839 in trading volume during the last 100 days, posting a change of -57.22%.
CVAC’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for CVAC stands at 0.07. Similarly, the long-term debt-to-equity ratio is also 0.06.
CVAC Stock Stochastic Average
CureVac N.V.’s raw stochastic average for the past 50 days is presently 6.92%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 10.20%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 18.96% and 19.65%, respectively.
